Frances Priddy

9PUBLICATIONS
29CO-AUTHORS
Preventative health careInnate immunityRadiation therapyImmunogenetics (incl. genetic immunology)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age.

|Apr 14, 2026
Evaluation of Cardiac Troponin Levels in Individuals Aged 12-30 Years Following mRNA-1273 Vaccination: Results From a Randomized Placebo-Controlled Trial.

Susan Pfeiffer, Margaret Rhee, Scott Striplin

|Feb 19, 2026
Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.

Erick F Mayer, Ann R Falsey, Cameron R Wolfe

|Dec 04, 2025
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants.

Amparo L Figueroa, Bethany Girard, Darin K Edwards

|Nov 25, 2025
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples.

Dean Follmann, Lauren Dang, Eric Chu

|Jun 04, 2025
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.

Erick F Mayer, Ann R Falsey, Rebecca Clark

Pageof 2

Frequent Collaborators

2 joint publications

Veronica Urdaneta

2 joint publications

Ann R Falsey

2 joint publications

Dean Follmann

2 joint publications

Hana M El Sahly